MYRIAD GENETICS, INC. (MYGN) Capital expenditures 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$15.6MFY2025 · since FY2016: $6.1M → $15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.6M | -17.9% |
| FY2024 | $19.0M | -69.9% |
| FY2023 | $63.2M | +39.5% |
| FY2022 | $45.3M | +151.7% |
| FY2021 | $18.0M | — |
| FY2019 | $10.2M | +18.6% |
| FY2018 | $8.6M | +2.4% |
| FY2017 | $8.4M | +37.7% |
| FY2016 | $6.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice